NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

BACKGROUND: Surgery remains the standard of care for localised renal cell carcinoma (RCC). Nevertheless, nearly 50% of patients with high-risk disease experience relapse after surgery, with distant sites being common. Considering improved outcomes in terms of disease-free survival with adjuvant immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Muhammad, Wood, Simon, Pryor, David, Moon, Daniel, Bressel, Mathias, Azad, Arun A., Mitchell, Catherine, Murphy, Declan, Zargar, Homi, Hardcastle, Nick, Kearsley, Jamie, Eapen, Renu, Wong, Lih Ming, Cuff, Katharine, Lawrentschuk, Nathan, Neeson, Paul J., Siva, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164766/
https://www.ncbi.nlm.nih.gov/pubmed/37168818
http://dx.doi.org/10.1016/j.conctc.2023.101145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164766/
https://www.ncbi.nlm.nih.gov/pubmed/37168818
http://dx.doi.org/10.1016/j.conctc.2023.101145

Ejemplares similares